World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
36
Citations
5019
World Ranking
9026
National Ranking
437

Sylvie Claeysen publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Sylvie Claeysen sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 76 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Sylvie Claeysen D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Sylvie Claeysen sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 36 D-Index — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • G protein-coupled receptor
  • Genetics

Her primary areas of study are Receptor, G protein-coupled receptor, Pharmacology, Partial agonist and Neuroscience. Her biological study spans a wide range of topics, including Molecular biology and Signal transduction. Her research integrates issues of Open reading frame and Drosophila Protein in her study of G protein-coupled receptor.

In her study, In vivo, Serotonin and G protein is inextricably linked to Agonist, which falls within the broad field of Pharmacology. The study incorporates disciplines such as Inverse agonist, 5-HT1 receptor, δ-opioid receptor and 5-HT7 receptor in addition to Neuroscience. Her work deals with themes such as Cystine knot and Rhodopsin-like receptors, which intersect with Cell biology.

Her most cited work include:

  • Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation (196 citations)
  • Engineering GPCR signaling pathways with RASSLs (188 citations)
  • 5-HT4 receptors. (180 citations)

What are the main themes of her work throughout her whole career to date?

Sylvie Claeysen focuses on Receptor, G protein-coupled receptor, Neuroscience, Cell biology and Biochemistry. Her work carried out in the field of Receptor brings together such families of science as Molecular biology and Pharmacology. Her G protein-coupled receptor research incorporates elements of 5-HT7 receptor, 5-HT receptor, Rhodopsin-like receptors, Metabotropic receptor and G protein.

Her study in Neuroscience is interdisciplinary in nature, drawing from both Inflammation, Dementia, Disease and Serotonin. Her research on Cell biology focuses in particular on Arrestin. Her research in the fields of Wild type and Mutant overlaps with other disciplines such as Hormone receptor, Rhodopsin and Thyrotropin receptor.

She most often published in these fields:

  • Receptor (84.27%)
  • G protein-coupled receptor (70.79%)
  • Neuroscience (51.69%)

What were the highlights of her more recent work (between 2014-2021)?

  • Neuroscience (51.69%)
  • Disease (32.58%)
  • Receptor (84.27%)

In recent papers she was focusing on the following fields of study:

Her main research concerns Neuroscience, Disease, Receptor, G protein-coupled receptor and In vivo. Her Neuroscience research is multidisciplinary, incorporating elements of Inflammation, Alzheimer's disease, Dementia and Serotonin. Her work on Amyloid is typically connected to Multi target as part of general Disease study, connecting several disciplines of science.

In the subject of general Receptor, her work in Serotonergic is often linked to Structure and function, thereby combining diverse domains of study. Her G protein-coupled receptor study results in a more complete grasp of Cell biology. Sylvie Claeysen combines subjects such as Internalization and Rhodopsin-like receptors with her study of Cell biology.

Between 2014 and 2021, her most popular works were:

  • Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride. (72 citations)
  • Serotonin: A New Hope in Alzheimer's Disease? (63 citations)
  • Serotonin: A New Hope in Alzheimer's Disease? (63 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • G protein-coupled receptor
  • Genetics

The scientist’s investigation covers issues in Synaptic cleft, Neuroprotection, Dementia, Disease and Symptomatic relief. Her Synaptic cleft research is multidisciplinary, relying on both Neuroscience and Serotonin.

Best Publications

  • Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation

    Joël Bockaert;Sylvie Claeysen;Carine Bécamel;Aline Dumuis

  • Engineering GPCR signaling pathways with RASSLs

    Bruce R. Conklin;Edward C. Hsiao;Sylvie Claeysen;Aline Dumuis

  • Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain.

    Sylvie Claeysen;Michèle Sebben;Carine Becamel;Joël Bockaert

  • 5-HT4 receptors.

    Joël Bockaert;S. Claeysen;Valerie Compan;Aline Dumuis

  • International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

    Nicholas M. Barnes;Gerard P. Ahern;Carine Becamel;Joël Bockaert

  • Drosophila molting neurohormone bursicon is a heterodimer and the natural agonist of the orphan receptor DLGR2.

    Fernando M. Mendive;Tom Van Loy;Sylvie Claeysen;Jeroen Poels

  • New sorting nexin (SNX27) and NHERF specifically interact with the 5-HT4(a) receptor splice variant: roles in receptor targeting

    Lara Joubert;Brendon Hanson;Gaël Barthet;Michèle Sebben

  • Cerebrovascular pathology during the progression of experimental Alzheimer's disease.

    Patrizia Giannoni;Margarita Arango-Lievano;Ines Das Neves;Marie-Claude Rousset

  • 5-HT4 receptors: History, molecular pharmacology and brain functions

    Joël Bockaert;Sylvie Claeysen;Sylvie Claeysen;Sylvie Claeysen;Valérie Compan;Valérie Compan;Valérie Compan;Aline Dumuis;Aline Dumuis;Aline Dumuis

  • Serotonin: A New Hope in Alzheimer's Disease?

    Sylvie Claeysen;Sylvie Claeysen;Sylvie Claeysen;Joël Bockaert;Joël Bockaert;Joël Bockaert;Patrizia Giannoni;Patrizia Giannoni;Patrizia Giannoni

  • Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.

    Christophe Rochais;Cédric Lecoutey;Florence Gaven;Florence Gaven;Florence Gaven;Patrizia Giannoni;Patrizia Giannoni;Patrizia Giannoni

  • An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor.

    Eneko Urizar;Eneko Urizar;Sylvie Claeysen;Xavier Deupí;Cedric Govaerts

  • Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

    Cédric Lecoutey;Damien Hedou;Thomas Freret;Patrizia Giannoni

  • 5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.

    Maud Cochet;Romain Donneger;Romain Donneger;Elisabeth Cassier;Elisabeth Cassier;Florence Gaven

  • Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease

    Patrizia Giannoni;Patrizia Giannoni;Florence Gaven;Florence Gaven;Dimitri de Bundel;Dimitri de Bundel;Kevin Baranger;Kevin Baranger

  • Alzheimer culprits: cellular crossroads and interplay.

    Sylvie Claeysen;Maud Cochet;Maud Cochet;Romain Donneger;Romain Donneger;Aline Dumuis;Aline Dumuis

  • G protein-coupled receptors: dominant players in cell-cell communication.

    Joël Bockaert;Sylvie Claeysen;Carine Becamel;Sylvie Pinloche

  • A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL).

    Sylvie Claeysen;Lara Joubert;Michèle Sebben;Joël Bockaert

  • Cloning, expression and pharmacology of the mouse 5-HT4L receptor

    Sylvie Claeysen;Michèle Sebben;Laurent Journot;Joël Bockaert

  • Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors.

    Lucie P. Pellissier;Jessica Sallander;Mercedes Campillo;Florence Gaven

  • G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient

    Lucie P. Pellissier;Lucie P. Pellissier;Gaël Barthet;Gaël Barthet;Florence Gaven;Florence Gaven;Elisabeth Cassier;Elisabeth Cassier

Frequent Co-Authors

Joël Bockaert
Joël Bockaert University of Montpellier
Aline Dumuis
Aline Dumuis Centre national de la recherche scientifique, CNRS
Philippe Marin
Philippe Marin University of Montpellier
Eric Reiter
Eric Reiter François Rabelais University
Nicola Marchi
Nicola Marchi Centre national de la recherche scientifique, CNRS
Leonardo Pardo
Leonardo Pardo Autonomous University of Barcelona
Gilbert Vassart
Gilbert Vassart Université Libre de Bruxelles
Serge Mignani
Serge Mignani Universidade da Madeira
Sabine Costagliola
Sabine Costagliola Université Libre de Bruxelles
Emmanuel Valjent
Emmanuel Valjent Centre national de la recherche scientifique, CNRS

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Neuroscience can open doors to a wide array of careers within mental health, research, and clinical practice. Many students choose complementary online degrees to diversify their skill set and improve career options. For example, those interested in therapy may consider an mft degree to specialize in marriage and family counseling.

A masters in psychology online cheap can boost your expertise in human behavior and cognition, offering additional insights useful in neuroscience-related roles. Similarly, enrolling in an online psychology degree cheap is a cost-effective route for those starting out or looking to pivot into related fields.

Some career paths in neuroscience, such as social work in a clinical setting, may require a relevant master’s qualification. In this case, pursuing masters in social work online programs can provide the credentials needed for licensure and specialized clinical roles.

Best Scientists Citing Sylvie Claeysen

Trending Scientists

Recently Published Articles